Sponsored by
Associated Press
  •  

Movers Roundup: Amylin, ImClone Systems

By Associated Press March 19, 2008

0 Recommendations

Among the stock activity stories for Wednesday, March 19, from AP Financial News:

NEW YORK (AP) _ Shares of Amylin Pharmaceuticals Inc. jumped Wednesday after a Piper Jaffray analyst said the company's developing once-weekly diabetes treatment will likely be more effective than a drug being developed by Novo Nordisk.

NEW YORK (AP) _ A Citi Investment Research analyst upgraded shares of ImClone Systems Inc. Wednesday, saying ImClone's cancer drug Erbitux will be effective enough against lung cancer to get attention from doctors.

NEW YORK (AP) _ Shares of Monster Worldwide Inc. fell to a multiyear low Wednesday after the online career services company said it expects its first-quarter expenses to be higher than analysts anticipate.

NEW YORK (AP) _ Shares of oilfield service provider Dawson Geophysical Co. fell more than 6 percent Wednesday after an analyst said most of the company's growth potential is already priced into the stock.

NEW YORK (AP) _ TheStreet.com Inc.'s shares fell Wednesday as an analyst lowered his 2008 estimates for the financial news service, saying the cuts were triggered by a downturn in the stock market, which may hurt subscription sales.

Compare Brokers

TD AMERITRADE
more info
ShareBuilder
more info
Power E*Trade

more info
Scottrade
more info
Fool Disclosure

DocumentId: 602859, ~/articles/articlehandler.aspx, 5/17/2008 6:48:17 AM

Sign up for FREE Motley Fool site access!

Already registered? Login Here

It’s FREE! Enter your email address, and we’ll rush you to the article you're looking for right now.

Privacy / Legal Information

We will use your email address only to keep you informed about updates to our web site and about other products and services that we think might interest you. The Motley Fool respects your privacy. Please read our Privacy Statement

.

Related Tickers

Amylin Pharmaceuticals, Inc.

AMLN Up! $32.15 +1.52 (+4.96%) 4:00 PM
CAPS Rating:
210 Outperforms
43 Underperforms
Rate This Stock

Major Indices

S&P 5001,425.35+0.13%
DJIA12,986.80 -0.05%
RSL 2K741.17 -0.30%
NASD2,528.85 -0.19%
Updated: 4:02:51 PM
Sponsored by:

The Motley Poll

How would you describe your level of investing experience?

Sponsored by: